SCHEMBL19959922

SCHEMBL19959922

S=P(c1ccccc1)(c1ccc2ccc3ccccc3c2c1)c1ccc2nc3c4ccccc4c4ccccc4n3c2c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.38
MAPT P10636 4/20 0.38
HSD17B10 Q99714 3/20 0.38
LMNA P02545 3/20 0.38
POLB P06746 2/20 0.38
TP53 P04637 1/20 0.38
ALDH1A1 P00352 9/20 0.37
HPGD P15428 7/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
AHR P35869 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
NPSR1 Q6W5P4 2/20 0.33
HIF1A Q16665 2/20 0.33
CYP1B1 Q16678 1/20 0.33
TSHR P16473 1/20 0.32
CYP3A4 P08684 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19959871 0.94 KDM4E (0.35) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19965895 0.93 KDM4E (0.38) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19959941 0.92 KDM4E (0.43) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19959916 0.92 KDM4E (0.37) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19959835 0.90 KDM4E (0.37) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19959947 0.90 KDM4E (0.41) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19959920 0.88 KDM4E (0.38) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19960236 0.88 KDM4E (0.40) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19965965 0.88 ALDH1A1 (0.36) KDM4EMAPTHSD17B10LMNAPOLB
SCHEMBL19960245 0.87 KMT2A (0.39) KDM4EMAPTHSD17B10LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885HSD17B10 2882/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885HSD17B10 2882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.